Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
Clinical trial NCT00225056 · TERMINATED
Trial details
- NCT number
- NCT00225056
- Sponsor
- Oncology Specialties, Alabama
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.